Literature DB >> 36013558

Salivary Biomarkers Associated with Psychological Alterations in Patients with Diabetes: A Systematic Review.

Guillermo Bargues-Navarro1, Vanessa Ibáñez-Del Valle1,2,3, Nisrin El Mlili4,5, Omar Cauli1,2,3.   

Abstract

The care of individuals with diabetes needs a holistic perspective, taking into account both the physical disease and the mental health problems that may be associated. Different studies show a higher prevalence of depression or anxiety issues in diabetes patients than in the general population, which is why diabetes can be considered one of the chronic diseases in which psychological care is crucial to maintain quality of life. The objective of this review is to examine the published articles that relate the bidirectional associations between objective and subjective measures of anxiety, depressive symptomatology, stress, sleep quality, and salivary biomarkers in patients with diabetes. For this, a search was carried out in the electronic databases PubMed, Cochrane, and SCOPUS using the keywords "diabetes", "saliva", "sleep", "anxiety", "depression", and "stress" for works published up until May 2022 and limited to the English and Spanish languages. The sample comprised 14 articles, 5 of which analysed the associations between depressive symptomatology and salivary biomarkers in people with diabetes. Among the salivary biomarkers most frequently used to evaluate psychological alterations in persons with diabetes are cortisol and melatonin. Thus, significant changes in the levels of these biomarkers were observed in most studies. Four out of five studies reported a statistically significant relationship between increased salivary cortisol in the evening/midnight or the cortisol awakening response and depressive symptoms. In contrast, lower cortisol levels upon waking in the morning were observed when there was no depression or anxiety. Regarding the association between salivary cortisol values and sleep quality in patients with diabetes, lower morning cortisol values related to prolonged nighttime sleep were common in the analysed studies. Low melatonin concentrations showed a negative correlation with sleep quality. As it is an easy-to-apply and non-invasive method, the measurement of salivary biomarkers can be very useful for predicting psychological alterations in patients with diabetes. Further scientific studies are required to determine the sensitivity of these biological substances acting as biomarkers for detecting sleep disorders and psychological alterations.

Entities:  

Keywords:  anxiety; cortisol; depression; diabetes; melatonin; saliva; sleep; stress

Mesh:

Substances:

Year:  2022        PMID: 36013558      PMCID: PMC9416232          DOI: 10.3390/medicina58081091

Source DB:  PubMed          Journal:  Medicina (Kaunas)        ISSN: 1010-660X            Impact factor:   2.948


  75 in total

1.  Association of Depressive and Anxiety Disorders With Diagnosed Versus Undiagnosed Diabetes: An Epidemiological Study of 90,686 Participants.

Authors:  Maaike Meurs; Annelieke M Roest; Bruce H R Wolffenbuttel; Ronald P Stolk; Peter de Jonge; Judith G M Rosmalen
Journal:  Psychosom Med       Date:  2016 Feb-Mar       Impact factor: 4.312

2.  Stress exposure and psychological stress responses are related to glucose concentrations during pregnancy.

Authors:  Antje Horsch; Ji Seon Kang; Yvan Vial; Ulrike Ehlert; Ayala Borghini; Pedro Marques-Vidal; Ingo Jacobs; Jardena J Puder
Journal:  Br J Health Psychol       Date:  2016-05-12

Review 3.  Salivary Inflammatory Molecules as Biomarkers of Sleep Alterations: A Scoping Review.

Authors:  Vanessa Ibáñez-Del Valle; Rut Navarro-Martínez; Maria Luisa Ballestar-Tarin; Omar Cauli
Journal:  Diagnostics (Basel)       Date:  2021-02-10

4.  Salivary melatonin levels and sleep-wake rhythms in pregnant women with hypertensive and glucose metabolic disorders: A prospective analysis.

Authors:  Mieko Shimada; Hiroyuki Seki; Michikazu Samejima; Mako Hayase; Fumie Shirai
Journal:  Biosci Trends       Date:  2016-02-06       Impact factor: 2.400

5.  Diabetes-related distress and daily cortisol output in people with Type 2 diabetes.

Authors:  Hetashi Bawa; Lydia Poole; Debbie Cooke; Laura Panagi; Andrew Steptoe; Ruth A Hackett
Journal:  Diabetes Res Clin Pract       Date:  2020-09-28       Impact factor: 5.602

6.  Glucose control during a driving training in patients with type 1 and type 2 diabetes mellitus - a randomised, controlled trial.

Authors:  R Truninger; H Uthoff; J Capraro; B Frauchiger; G A Spinas; P Wiesli
Journal:  Exp Clin Endocrinol Diabetes       Date:  2013-06-13       Impact factor: 2.949

Review 7.  Circadian rhythms in the eye: the physiological significance of melatonin receptors in ocular tissues.

Authors:  Allan F Wiechmann; Jody A Summers
Journal:  Prog Retin Eye Res       Date:  2007-11-23       Impact factor: 21.198

8.  Assessing heart rate variability in type 1 diabetes mellitus-Psychosocial stress a possible confounder.

Authors:  Eva Kristiansen; Pär Wanby; Karin Åkesson; Peter Blomstrand; Lars Brudin; Johanna Thegerström
Journal:  Ann Noninvasive Electrocardiol       Date:  2020-04-30       Impact factor: 1.468

9.  The Mental Status in Patients with Diabetes Mellitus Admitted to a Diabetes Clinic After Presenting in the Emergency Room: The Application of the SCL-90 Scale.

Authors:  Oana Albai; Mirela Frandes; Romulus Timar; Bogdan Timar; Teodora Anghel; Vlad Florian Avram; Alexandra Sima
Journal:  Diabetes Metab Syndr Obes       Date:  2021-04-28       Impact factor: 3.168

Review 10.  Type 2 Diabetes Mellitus and Alzheimer's Disease: Role of Insulin Signalling and Therapeutic Implications.

Authors:  Andrea Tumminia; Federica Vinciguerra; Miriam Parisi; Lucia Frittitta
Journal:  Int J Mol Sci       Date:  2018-10-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.